Use when packaging AAAI code, data, multimedia appendices, technical appendices, reproducibility evidence, and post-acceptance artifact releases without violating double-blind or immutable-supplement rules.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
Use when drafting an AAAI author response (rebuttal) under the single short character-limited author-feedback window, the no-URL rule, no-new-results guidance, AI-generated-review handling, and the AAAI two-phase review process where Phase-2 papers receive one feedback round before SPC/AC discussion.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
실행 점수 미검증
설치 방법 보기설치하기 전에 에이전트에게 전달되는 지시 내용을 확인할 수 있습니다.
Use this after AAAI reviews are released. AAAI rebuttal space is scarce: the AAAI-26 FAQ allowed a single 2500-character response, disallowed URLs, and discouraged new results. AAAI-27 has not yet published its own rebuttal FAQ — its author feedback window is 2026-10-19 to 10-25 — so treat those limits as the prior cycle's shape and reopen the current FAQ before drafting.
Author feedback at AAAI is read by human reviewers and weighed in SPC/AC discussion, not by the non-decisional AI review. With one short response and no second round, spend every character on the concern most likely to flip a borderline decision. Triage each reviewer point into a lane:
A multi-agent-coordination paper gets two borderline scores. Reviewer 1 wrongly says the protocol ignores communication cost; Reviewer 2 asks for a human-baseline study. Triage: R1 is decision- critical, so sentence one corrects it and cites Section 4's cost ledger; R2's request is out of scope, so one sentence notes the simulator already bounds it and limits the claim to simulated agents. Tone and the AI review's nit are cut to stay under budget.
[Response budget] <characters used / limit>
[Priority issue] <reviewer or AI-review concern>
[Draft rebuttal] <AAAI-ready text, no URLs>
[Submitted evidence anchor] <section/table/figure/checklist/supplement item>
[Cut list] <what to delete if over limit>
아직 리뷰가 없습니다. 사용해 본 소감을 남겨 주세요.
로그인 없이 쓸 수 있습니다. 사용 후기, 질문, 작동하지 않은 환경 등을 편하게 남겨 주세요.
아직 댓글이 없습니다. 첫 댓글을 남겨 보세요.
Use when packaging AAAI code, data, multimedia appendices, technical appendices, reproducibility evidence, and post-acceptance artifact releases without violating double-blind or immutable-supplement rules.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
Use when preparing an accepted AAAI paper for camera-ready source submission to AAAI Press, including proceedings page limits, two-column template compliance, copyright transfer, purchased extra technical pages, deanonymization, registration, oral or poster presentation, and final public artifact release.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
Use when designing or auditing AAAI experiments for the broad-AI program committee, including baselines, ablations, statistical significance, robustness, human evaluation, AI-for-Social-Impact and alignment/safety evidence, compute and cost reporting, and reproducibility-checklist alignment for Phase-1 survival.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
Use when positioning an AAAI paper's novelty against archival work, contemporaneous arXiv or workshop papers, and AAAI/IJCAI/NeurIPS/ICML/ICLR neighbors across the broad AI scope, while staying inside AAAI's dual-submission and AI-as-source policy constraints and writing a related-work section legible to non-specialist reviewers.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
Use when strengthening an AAAI paper's reproducibility checklist (placed after references), experimental traceability, seed and hyperparameter reporting, compute and cost disclosure, dataset access and licensing, code/data ZIP readiness, and the claim-to-evidence map that Phase-1 reviewers use to judge rigor across AAAI's broad AI scope.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
Use when explaining or planning around AAAI's two-phase review process, Phase 1 rejection risk, Phase 2 additional reviews, AI-assisted review pilot, author feedback, SPC/AC discussion, and final decisions.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.